Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Balancing efficiency and fairness in liver transplant access: tradeoff curves for the assessment of organ distribution policies.

Bertsimas D, Papalexopoulos T, Trichakis N, Wang Y, Hirose R, Vagefi PA.

Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000003017. [Epub ahead of print]

PMID:
31644494
2.

Search for the best site in islet xenotransplantation.

Ekser B, Vagefi PA.

Int J Surg. 2019 Oct;70:106-107. doi: 10.1016/j.ijsu.2019.08.001. Epub 2019 Aug 2. No abstract available.

PMID:
31382024
3.

Editorial: Xenotransplantation: the summit climb.

Vagefi PA.

Curr Opin Organ Transplant. 2019 Oct;24(5):515-516. doi: 10.1097/MOT.0000000000000677. No abstract available.

PMID:
31348017
4.

Emphysematous Esophagogastritis after Hepatic Resection.

Letica-Kriegel A, Patel MS, Muniappan A, Vagefi PA.

Am Surg. 2019 Feb 1;85(2):e86-e88. No abstract available.

PMID:
30819313
5.

Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.

Lee GC, Ferrone CR, Vagefi PA, Uppot RN, Tanabe KK, Lillemoe KD, Blaszkowsky LS, Qadan M.

Am J Surg. 2019 Jul;218(1):157-163. doi: 10.1016/j.amjsurg.2018.12.067. Epub 2019 Jan 3.

PMID:
30635211
6.

Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants.

AbdulRahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, MacConmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B.

Liver Transpl. 2019 Mar;25(3):411-424. doi: 10.1002/lt.25390.

PMID:
30506870
7.

Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model.

Navarro-Alvarez N, Machaidze Z, Schuetz C, Zhu A, Liu WH, Shah JA, Vagefi PA, Elias N, Buhler L, Sachs DH, Markmann JF, Yeh H.

PLoS One. 2018 Nov 21;13(11):e0207272. doi: 10.1371/journal.pone.0207272. eCollection 2018.

8.

Amino acid and lipid profiles following pig-to-primate liver xenotransplantation.

Shah JA, Patel MS, Louras N, Sachs DH, Vagefi PA.

Xenotransplantation. 2019 Mar;26(2):e12473. doi: 10.1111/xen.12473. Epub 2018 Nov 16.

PMID:
30443967
9.

Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation.

Bertsimas D, Kung J, Trichakis N, Wang Y, Hirose R, Vagefi PA.

Am J Transplant. 2019 Apr;19(4):1109-1118. doi: 10.1111/ajt.15172. Epub 2018 Dec 6.

PMID:
30411495
10.

Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

Michelakos T, Xourafas D, Qadan M, Pieretti-Vanmarcke R, Cai L, Patel MS, Adler JT, Fontan F, Basit U, Vagefi PA, Elias N, Tanabe KK, Berger D, Yeh H, Markmann JF, Chang DC, Ferrone CR.

J Gastrointest Surg. 2019 Jun;23(6):1135-1142. doi: 10.1007/s11605-018-3946-z. Epub 2018 Sep 14.

PMID:
30218342
11.

How Good Is Good? Benchmarking and the Quest for Quality Improvement in Liver Transplantation.

Patel MS, Hirose R, Vagefi PA.

Ann Surg. 2018 Mar;267(3):426-427. doi: 10.1097/SLA.0000000000002551. No abstract available.

PMID:
29319540
12.

The reinvention of xenotransplantation.

Vagefi PA.

Curr Opin Organ Transplant. 2017 Dec;22(6):511-512. doi: 10.1097/MOT.0000000000000474. No abstract available.

PMID:
28961579
13.

Liver xenotransplantation.

Patel MS, Louras N, Vagefi PA.

Curr Opin Organ Transplant. 2017 Dec;22(6):535-540. doi: 10.1097/MOT.0000000000000459. Review.

14.

Is Annual Volume Enough? The Role of Experience and Specialization on Inpatient Mortality After Hepatectomy.

Hashimoto DA, Bababekov YJ, Mehtsun WT, Stapleton SM, Warshaw AL, Lillemoe KD, Chang DC, Vagefi PA.

Ann Surg. 2017 Oct;266(4):603-609. doi: 10.1097/SLA.0000000000002377.

15.

Accept or Decline? An Analytics-Based Decision Tool for Kidney Offer Evaluation.

Bertsimas D, Kung J, Trichakis N, Wojciechowski D, Vagefi PA.

Transplantation. 2017 Dec;101(12):2898-2904. doi: 10.1097/TP.0000000000001824.

PMID:
28514250
16.

Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade.

Shah JA, Patel MS, Elias N, Navarro-Alvarez N, Rosales I, Wilkinson RA, Louras NJ, Hertl M, Fishman JA, Colvin RB, Cosimi AB, Markmann JF, Sachs DH, Vagefi PA.

Am J Transplant. 2017 Aug;17(8):2178-2185. doi: 10.1111/ajt.14341. Epub 2017 Jun 6.

17.

Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report.

Villani V, Gupta N, Elias N, Vagefi PA, Markmann JF, Paul E, Traum AZ, Yeh H.

Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12901. Epub 2017 Mar 5.

PMID:
28261895
18.

Deceased Organ Donor Management: Does Hospital Volume Matter?

Patel MS, Mohebali J, Sally M, Groat T, Vagefi PA, Chang DC, Malinoski DJ.

J Am Coll Surg. 2017 Mar;224(3):294-300. doi: 10.1016/j.jamcollsurg.2016.12.004. Epub 2017 Jan 17.

PMID:
28108262
19.

Percutaneous creation of biliary-enteric neoanastomosis for anastomotic biliary occlusion following living donor liver transplantation.

McCarthy CJ, Thabet A, Yamada K, Mueller PR, Vagefi PA.

Liver Transpl. 2017 Feb;23(2):262-265. doi: 10.1002/lt.24674. Epub 2017 Jan 6. No abstract available.

20.

 High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.

Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):888-894.

21.

Readmission following liver transplantation: an unwanted occurrence but an opportunity to act.

Patel MS, Mohebali J, Shah JA, Markmann JF, Vagefi PA.

HPB (Oxford). 2016 Nov;18(11):936-942. doi: 10.1016/j.hpb.2016.08.003. Epub 2016 Sep 15.

22.

The National Ambulatory Medical Care Survey: PAs and NPs in outpatient surgery.

Salibian AA, Mahboubi H, Patel MS, Kuan EC, Malinoski DJ, Vagefi PA, Djalilian HR.

JAAPA. 2016 May;29(5):47-53. doi: 10.1097/01.JAA.0000482302.40692.20.

PMID:
27124230
23.

Patients on state organ donor registries receive similar levels of intensive care compared to those who are not: an opportunity to increase public intent to donate.

Patel MS, Raza SS, Bhakta A, Ewing T, Bukur M, Vagefi PA, Salim A, Malinoski DJ.

Clin Transplant. 2016 Jun;30(6):682-7. doi: 10.1111/ctr.12734. Epub 2016 Apr 6.

PMID:
26992655
24.

CXCL13 is a plasma biomarker of germinal center activity.

Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM, Kendric K, Bélanger S, Kasturi SP, Landais E, Akondy RS, McGuire HM, Bothwell M, Vagefi PA, Scully E; IAVI Protocol C Principal Investigators, Tomaras GD, Davis MM, Poignard P, Ahmed R, Walker BD, Pulendran B, McElrath MJ, Kaufmann DE, Crotty S.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2702-7. doi: 10.1073/pnas.1520112113. Epub 2016 Feb 23.

25.

Pretransplantation Imaging Workup of the Liver Donor and Recipient.

Burk KS, Singh AK, Vagefi PA, Sahani D.

Radiol Clin North Am. 2016 Mar;54(2):185-97. doi: 10.1016/j.rcl.2015.09.010. Epub 2015 Dec 28. Review.

PMID:
26896219
26.

A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation.

Shah JA, Navarro-Alvarez N, DeFazio M, Rosales IA, Elias N, Yeh H, Colvin RB, Cosimi AB, Markmann JF, Hertl M, Sachs DH, Vagefi PA.

Ann Surg. 2016 Jun;263(6):1069-71. doi: 10.1097/SLA.0000000000001659. No abstract available.

PMID:
26825261
27.

High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.

Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA.

Ann Hepatol. 2016 Nov - Dec;15(6):888-894. doi: 10.5604/16652681.1222105.

28.

Liver transplantation utilizing a severely fractured graft: every organ counts.

Fong ZV, Patel MS, Yeh H, Markmann JF, Vagefi PA.

Ann Hepatol. 2016 Jan-Feb;15(1):131-4.

29.

Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes.

Heesters BA, Lindqvist M, Vagefi PA, Scully EP, Schildberg FA, Altfeld M, Walker BD, Kaufmann DE, Carroll MC.

PLoS Pathog. 2015 Dec 1;11(12):e1005285. doi: 10.1371/journal.ppat.1005285. eCollection 2015 Dec.

30.

The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-to-Baboon Liver Xenotransplantation.

Navarro-Alvarez N, Shah JA, Zhu A, Ligocka J, Yeh H, Elias N, Rosales I, Colvin R, Cosimi AB, Markmann JF, Hertl M, Sachs DH, Vagefi PA.

Am J Transplant. 2016 Jun;16(6):1715-1725. doi: 10.1111/ajt.13647. Epub 2016 Feb 5.

31.

Role of Locoregional Therapy and Predictors for Dropout in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.

Sheth RA, Patel MS, Koottappillil B, Shah JA, Oklu R, Mueller P, Vagefi PA, Ganguli S.

J Vasc Interv Radiol. 2015 Dec;26(12):1761-8; quiz 1768. doi: 10.1016/j.jvir.2015.08.015. Epub 2015 Sep 26.

PMID:
26419427
32.

Postnatal xenogeneic B-cell tolerance in swine following in utero intraportal antigen exposure.

Navarro Alvarez N, Zhu A, Arellano RS, Randolph MA, Duggan M, Scott Arn J, Huang CA, Sachs DH, Vagefi PA.

Xenotransplantation. 2015 Sep-Oct;22(5):368-78. doi: 10.1111/xen.12186. Epub 2015 Aug 28.

PMID:
26314946
33.

Progress towards inducing tolerance of pig-to-primate xenografts.

Vagefi PA, Shah JA, Sachs DH.

Int J Surg. 2015 Nov;23(Pt B):291-295. doi: 10.1016/j.ijsu.2015.07.720. Epub 2015 Aug 18. Review.

34.

Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.

Dumontet E, Danger R, Vagefi PA, Londoño MC, Pallier A, Lozano JJ, Giral M, Degauque N, Soulillou JP, Martínez-Llordella M, Lee H, Latournerie M, Boudjema K, Dulong J, Tarte K, Sanchez-Fueyo A, Feng S, Brouard S, Conchon S.

Liver Int. 2016 Mar;36(3):401-9. doi: 10.1111/liv.12917. Epub 2015 Aug 8.

35.

The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing.

Axelrod DA, Vagefi PA, Roberts JP.

Ann Surg. 2015 Aug;262(2):224-7. doi: 10.1097/SLA.0000000000001340. Review.

PMID:
26164429
36.

The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.

Patel MS, Kohn R, Kratz JR, Shah JA, Markmann JF, Vagefi PA.

J Am Coll Surg. 2015 Jun;220(6):1001-7. doi: 10.1016/j.jamcollsurg.2014.12.050. Epub 2015 Jan 21.

PMID:
25868408
37.

Anesthetic considerations in organ procurement surgery: a narrative review.

Anderson TA, Bekker P, Vagefi PA.

Can J Anaesth. 2015 May;62(5):529-39. doi: 10.1007/s12630-015-0345-8. Epub 2015 Feb 26. Review.

PMID:
25715847
38.

Obstructive jaundice caused by a giant non-parasitic hepatic cyst.

Mehtsun WT, Patel MS, Markmann JF, Hertl M, Vagefi PA.

Ann Hepatol. 2015 Mar-Apr;14(2):267-9. No abstract available.

39.

Successful long-term management of invasive cerebral fungal infection following liver transplantation.

Patel MS, Wright AJ, Kohn R, Markmann JF, Kotton CN, Vagefi PA.

Mycoses. 2015 Mar;58(3):181-6. doi: 10.1111/myc.12289. Epub 2015 Jan 15.

PMID:
25590987
40.

Commentary on: Mesohepatectomy for centrally located large hepatocellular carcinoma: indications, techniques, and outcomes.

Patel MS, Vagefi PA.

Surgery. 2014 Nov;156(5):1188-9. doi: 10.1016/j.surg.2014.06.009. Epub 2014 Oct 17. No abstract available.

PMID:
25444317
41.

Liver transplantation: it's all about location, location, location: in reply to Lee and colleagues.

Vagefi PA, Markmann JF.

J Am Coll Surg. 2014 Nov;219(5):1100-1. doi: 10.1016/j.jamcollsurg.2014.07.016. Epub 2014 Oct 17. No abstract available.

PMID:
25440036
42.

Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.

Vagefi PA, Dodge JL, Yao FY, Roberts JP.

Liver Transpl. 2015 Feb;21(2):187-94. doi: 10.1002/lt.24042.

43.

Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients.

Arroyo D, Chandran S, Vagefi PA, Wojciechowski D.

J Transplant. 2014;2014:107459. doi: 10.1155/2014/107459. Epub 2014 May 8.

44.

Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.

Brennan TV, Lunsford KE, Vagefi PA, Bostrom A, Ma M, Feng S.

Clin Transplant. 2015 Jan;29(1):34-43. doi: 10.1111/ctr.12479. Epub 2014 Nov 17.

45.

Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney disease.

Patel MS, Kandula P, Wojciechowski D, Markmann JF, Vagefi PA.

J Transplant. 2014;2014:675697. doi: 10.1155/2014/675697. Epub 2014 Aug 3.

46.

Increased transfusion-free survival following auxiliary pig liver xenotransplantation.

Yeh H, Machaidze Z, Wamala I, Fraser JW, Navarro-Alvarez N, Kim K, Schuetz C, Shi S, Zhu A, Hertl M, Elias N, Farkash EA, Vagefi PA, Varma M, Smith RN, Robson SC, Van Cott EM, Sachs DH, Markmann JF.

Xenotransplantation. 2014 Sep-Oct;21(5):454-64. doi: 10.1111/xen.12111. Epub 2014 Aug 1.

PMID:
25130043
47.

Multiple listings as a reflection of geographic disparity in liver transplantation.

Vagefi PA, Feng S, Dodge JL, Markmann JF, Roberts JP.

J Am Coll Surg. 2014 Sep;219(3):496-504. doi: 10.1016/j.jamcollsurg.2014.03.048. Epub 2014 May 2.

48.

Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.

Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA.

Liver Transpl. 2014 Oct;20(10):1202-10. doi: 10.1002/lt.23937. Epub 2014 Sep 3.

49.

The migrated liver transplantation candidate: insight into geographic disparities in liver distribution.

Kohn R, Kratz JR, Markmann JF, Vagefi PA.

J Am Coll Surg. 2014 Jun;218(6):1113-8. doi: 10.1016/j.jamcollsurg.2013.12.056. Epub 2014 Feb 28.

PMID:
24680570
50.

Evidence for a gene controlling the induction of transplantation tolerance.

Lee PW, Hanekamp JS, Villani V, Vagefi PA, Cina RA, Kamano C, O'Malley PE, Arn S, Yamada K, Sachs DH.

Am J Transplant. 2014 Apr;14(4):952-9. doi: 10.1111/ajt.12646. Epub 2014 Mar 4.

Supplemental Content

Loading ...
Support Center